Brief: Hologic Q4 Adjusted EBITDA USD 323.7 Million Vs. IBES Estimate USD 330.7 Million
Nov 04 (Reuters) - Hologic Q4 operating margin -23.3%. * Q4 gross margin 56.5% * Q4 adjusted gross margin 61.5% * Q4 net income USD 178.6 million * Q4 revenue USD 987.9 million vs. IBES estimate USD 976.7 million * Q4 adjusted operating margin 30% * Q4 adjusted net income USD 237.5 million vs. IBES estimate USD 238.6 million * outlook FY adjusted EPS USD 4.25-4.35 * outlook FY EPS USD 3.53-3.63
Recent news on Hologic
See all newsBrief: Blackstone And Tpg Complete Acquisition Of Hologic
Casey's General Stores edges higher ahead of replacing Hologic in S&P 500
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: S&P Dow Jones Indices Says Casey's General Stores Inc. Will Replace Hologic Inc. In The S&P 500 Effective Prior To The Market Open On April 9